Freestone Grove Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
24,111
-30,000
-55% -$473K ﹤0.01% 696
2026
Q1
$776K Buy
+54,111
New +$898K 0.01% 523

Other funds holding SHC

Freestone Grove Partners's SHC Position: Q2 2026 in Review

Freestone Grove Partners reduced its Sotera Health (SHC) stake by 55% in Q2 2026, selling an estimated $473K and leaving 24,111 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Freestone Grove Partners first reported a position in SHC in Q1 2026 and has held it in 2 quarters since. The position peaked at $776K in Q1 2026. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Freestone Grove Partners held 24,111 shares of Sotera Health worth $428K as of Q2 2026.
  • Freestone Grove Partners sold 30,000 Sotera Health shares in Q2 2026, an estimated $473K.
  • Sotera Health made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #696 holding.
  • Freestone Grove Partners first reported a position in Sotera Health in Q1 2026 and has held it in 2 quarters since.
  • Freestone Grove Partners's Sotera Health position peaked at $776K in Q1 2026.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.